H. Vangerow

机构：Boehringer Ingelheim (Germany)

发表论文 8 篇 · 总被引 111 次 · h-index 5

代表论文

• Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials (2018 · Open Forum Infectious Diseases · 被引 42)
• Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open‐Label, Randomized Study (2017 · Clinical Pharmacology & Therapeutics · 被引 37)
• A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis (2016 · Data Archiving and Networked Services (DANS) · 被引 14)
• Diagnoses of Gastrointestinal Cancers After Gastrointestinal Bleeding in Patients Receiving Clopidogrel or Warfarin (2013 · Current Drug Safety · 被引 11)
• Phase II Randomized Trial of BI 730357, an Oral RORγt Inhibitor, for Moderate-to-Severe Plaque Psoriasis (2025 · Journal of Investigative Dermatology · 被引 6)
• The efficacy and safety of ixekizumab, adalimumab, and placebo in patients with psoriatic arthritis naive to biological disease-modifying anti-rheumatic drugs : a double-blind phase 3 study (2016 · Data Archiving and Networked Services (DANS) · 被引 1)